{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:19:37Z","timestamp":1791004777078,"version":"4.1.0"},"reference-count":206,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Influenza viruses cause annual seasonal epidemics and occasional pandemics of human respiratory disease. Influenza virus infections represent a serious public health and economic problem, which are most effectively prevented through vaccination. However, influenza viruses undergo continual antigenic variation, which requires either the annual reformulation of seasonal influenza vaccines or the rapid generation of vaccines against potential pandemic virus strains. The segmented nature of influenza virus allows for the reassortment between two or more viruses within a co-infected cell, and this characteristic has also been harnessed in the laboratory to generate reassortant viruses for their use as either inactivated or live-attenuated influenza vaccines. With the implementation of plasmid-based reverse genetics techniques, it is now possible to engineer recombinant influenza viruses entirely from full-length complementary DNA copies of the viral genome by transfection of susceptible cells. These reverse genetics systems have provided investigators with novel and powerful approaches to answer important questions about the biology of influenza viruses, including the function of viral proteins, their interaction with cellular host factors and the mechanisms of influenza virus transmission and pathogenesis. In addition, reverse genetics techniques have allowed the generation of recombinant influenza viruses, providing a powerful technology to develop both inactivated and live-attenuated influenza vaccines. In this review, we will summarize the current knowledge of state-of-the-art, plasmid-based, influenza reverse genetics approaches and their implementation to provide rapid, convenient, safe and more effective influenza inactivated or live-attenuated vaccines.<\/jats:p>","DOI":"10.3390\/ijms18010020","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T09:48:53Z","timestamp":1482400133000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Reverse Genetics Approaches for the Development of Influenza Vaccines"],"prefix":"10.3390","volume":"18","author":[{"given":"Aitor","family":"Nogales","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7084-0804","authenticated-orcid":false,"given":"Luis","family":"Mart\u00ednez-Sobrido","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"ref_1","unstructured":"Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., and Martin, M.A. (2007). Fields Virology, Lippincott Williams & Wilkins. [5th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Steel, J., Lowen, A.C., Mubareka, S., and Palese, P. (2009). Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E\/701N. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000252"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev.micro.59.030804.121059","article-title":"The origins of new pandemic viruses: The acquisition of new host ranges by canine parvovirus and influenza A viruses","volume":"59","author":"Parrish","year":"2005","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/jvi.66.2.1129-1138.1992","article-title":"Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts","volume":"66","author":"Bean","year":"1992","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00239-008-9119-z","article-title":"The evolutionary dynamics of human influenza B virus","volume":"66","author":"Chen","year":"2008","journal-title":"J. Mol. Evol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.288.5468.1051","article-title":"Influenza B virus in seals","volume":"288","author":"Osterhaus","year":"2000","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/rna.8.2.14513","article-title":"The influenza virus rna synthesis machine: Advances in its structure and function","volume":"8","author":"Jorba","year":"2011","journal-title":"RNA Biol."},{"key":"ref_8","first-page":"121","article-title":"Orthomyxovirus replication, transcription, and polyadenylation","volume":"283","author":"Neumann","year":"2004","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1128\/jvi.64.11.5669-5673.1990","article-title":"Determination 0of influenza virus proteins required for genome replication","volume":"64","author":"Huang","year":"1990","journal-title":"J. Virol."},{"key":"ref_10","unstructured":"Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., and Martin, M.A. (2007). Fields Virology, Lippincott Williams & Wilkins. [5th ed.]."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1073\/pnas.84.9.2703","article-title":"Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs","volume":"84","author":"Stoeckle","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1128\/JVI.01440-14","article-title":"Influenza A and B virus intertypic reassortment through compatible viral packaging signals","volume":"88","author":"Baker","year":"2014","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.026187-0","article-title":"Molecular studies of influenza B virus in the reverse genetics era","volume":"92","author":"Jackson","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wise, H.M., Hutchinson, E.C., Jagger, B.W., Stuart, A.D., Kang, Z.H., Robb, N., Schwartzman, L.M., Kash, J.C., Fodor, E., and Firth, A.E. (2012). Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002998"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/j.1460-2075.1990.tb07446.x","article-title":"Eukaryotic coupled tanslation of tandem cistrons: Identification of the influenza B virus BM2 polypeptide","volume":"9","author":"Horvath","year":"1990","journal-title":"EMBO J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/prot.340140302","article-title":"The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor","volume":"14","author":"Varghese","year":"1992","journal-title":"Proteins"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0022-2836(92)90687-F","article-title":"Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex","volume":"227","author":"Tulip","year":"1992","journal-title":"J. Mol. Biol."},{"key":"ref_19","first-page":"359","article-title":"Evolution and ecology of influenza A viruses","volume":"385","author":"Yoon","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., and Gomez, J. (2013). New world bats harbor diverse influenza A viruses. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003657"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1128\/JVI.78.23.12817-12828.2004","article-title":"Multiple genotypes of influenza B virus circulated between 1979 and 2003","volume":"78","author":"McCullers","year":"2004","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/jvi.64.6.2860-2865.1990","article-title":"Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in japan: Cocirculating lineages in the same epidemic season","volume":"64","author":"Kanegae","year":"1990","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the united states","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcv.2007.11.026","article-title":"Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan","volume":"42","author":"Li","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijid.2005.10.008","article-title":"Medically attended pediatric influenza during the resurgence of the victoria lineage of influenza B virus","volume":"11","author":"Hite","year":"2007","journal-title":"Int. J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.bi.52.070183.002343","article-title":"The gene structure and replication of influenza virus","volume":"52","author":"Lamb","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1099\/vir.0.017608-0","article-title":"Genome packaging in influenza A virus","volume":"91","author":"Hutchinson","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tim.2014.04.001","article-title":"Selective packaging of the influenza A genome and consequences for genetic reassortment","volume":"22","author":"Gerber","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/vir.0.2008\/004606-0","article-title":"The multifunctional NS1 protein of influenza A viruses","volume":"89","author":"Hale","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Paterson, D., and Fodor, E. (2012). Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003019"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/irv.12081","article-title":"Improving influenza vaccine virus selection: Report of a WHO informal consultation held at WHO headquarters, geneva, switzerland, 14\u201316 June 2010","volume":"7","author":"Ampofo","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.vaccine.2009.11.043","article-title":"Epidemiological, antigenic and genetic characteristics of seasonal influenza A (H1N1), a(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009\u20132010 northern hemisphere season","volume":"28","author":"Barr","year":"2010","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF01719678","article-title":"Influenza: Global surveillance for epidemic and pandemic variants","volume":"10","author":"Cox","year":"1994","journal-title":"Eur. J. Epidemiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2011.09.037","article-title":"Novel vaccines against influenza viruses","volume":"162","author":"Kang","year":"2011","journal-title":"Virus Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-2007-976487","article-title":"Influenza: Evolving strategies in treatment and prevention","volume":"28","author":"Lynch","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the us: Measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2005.07.046","article-title":"A review of vaccine research and development: Human acute respiratory infections","volume":"23","author":"Girard","year":"2005","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00019053-200826110-00004","article-title":"The impact of influenza on working days lost: A review of the literature","volume":"26","author":"Keech","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.2105\/AJPH.2012.301137","article-title":"The burden of influenza B: A structured literature review","volume":"103","author":"Schmier","year":"2013","journal-title":"Am. J. Public Health"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/hv.8.1.17622","article-title":"Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly","volume":"8","author":"Gasparini","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: The challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.virusres.2004.02.013","article-title":"Reassortment and evolution of current human influenza A and B viruses","volume":"103","author":"Xu","year":"2004","journal-title":"Virus Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1073\/pnas.1113801108","article-title":"Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses","volume":"108","author":"Sandbulte","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","unstructured":"Knipe, D.M., and Howley, P.M. (2013). Fields Virology, Lippincott Williams & Wilkins. [6th ed.]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01318082","article-title":"Intrinsic interference between influenza A and B viruses","volume":"73","author":"Mikheeva","year":"1982","journal-title":"Arch. Virol."},{"key":"ref_50","unstructured":"Knipe, D.M., and Howley, P.M. (2013). Fields Virology, Wolters Kluwer\/Lippincott Williams & Wilkins Health. [6th ed.]."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 influenza: The mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_52","unstructured":"CDC (2009). Update: Infections with a swine\u2014Origin influenza A (H1N1) virus\u2014United States and other countries, April 28, 2009. MMWR Morb. Mortal. Wkly. Rep., 58, 431\u2013433."},{"key":"ref_53","unstructured":"WHO Pandemic (H1N1) 2009\u2014Update 112. Available online: http:\/\/www.who.int\/csr\/don\/2010_08_06\/en\/index.html."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMp1304661","article-title":"Global concerns regarding novel influenza A (H7N9) virus infections","volume":"368","author":"Uyeki","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_55","first-page":"3","article-title":"Pandemic influenza as a current threat","volume":"333","author":"Yen","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0950268802008166","article-title":"A large outbreak of influenza A and B on a cruise ship causing widespread morbidity","volume":"130","author":"Brotherton","year":"2003","journal-title":"Epidemiol. Infect."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"CDC (2001). From the centers for disease control and prevention. Influenza B virus outbreak in a cruise ship\u2014Northern europe, 2000. JAMA, 285, 1833\u20131834.","DOI":"10.1001\/jama.285.14.1833"},{"key":"ref_58","first-page":"269","article-title":"An outbreak of influenza B at an indiana boarding school: Estimate of vaccine efficacy","volume":"97","author":"DeStefano","year":"1982","journal-title":"Public Health Rep."},{"key":"ref_59","first-page":"6","article-title":"An outbreak of influenza B in a closed community school in Uganda","volume":"54","author":"Fayinka","year":"1977","journal-title":"East. Afr. Med. J."},{"key":"ref_60","first-page":"332","article-title":"An outbreak of influenza due to type B virus in a residential boys\u2019 school in Malaya","volume":"10","author":"Thomson","year":"1956","journal-title":"Med. J. Malaya"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"Tran","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1016\/j.vaccine.2007.06.066","article-title":"Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults","volume":"25","author":"Belshe","year":"2007","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1016\/j.vaccine.2012.09.071","article-title":"Development of new generation influenza vaccines: Recipes for success?","volume":"30","author":"Pronker","year":"2012","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"Flublok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza. Other Respir. Viruses"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1128\/JVI.01081-13","article-title":"Protection against lethal influenza with a viral mimic","volume":"87","author":"Baker","year":"2013","journal-title":"J. Virol."},{"key":"ref_70","unstructured":"Sun, W. (2012). Approval Letter\u2014Fluarix Quadrivalent (BL 125127\/513)."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/595861","article-title":"Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004\u20132005 season to the 2006\u20132007 season","volume":"199","author":"Belongia","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: Prospects and challenges","volume":"64","author":"Pica","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1378\/chest.100.4.977","article-title":"Superiority of live-attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults","volume":"100","author":"Gorse","year":"1991","journal-title":"Chest"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3201\/eid1201.051186","article-title":"Antiviral response in pandemic influenza viruses","volume":"12","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1469-0691.2003.00564.x","article-title":"Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors","volume":"9","author":"Oxford","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1128\/JVI.01424-10","article-title":"Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models","volume":"84","author":"Seibert","year":"2010","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jinf.2010.10.003","article-title":"Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review","volume":"62","author":"Jackson","year":"2011","journal-title":"J. Infect."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Nguyen, J.T., Hoopes, J.D., Le, M.H., Smee, D.F., Patick, A.K., Faix, D.J., Blair, P.J., de Jong, M.D., Prichard, M.N., and Went, G.T. (2010). Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009332"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"Gubareva","year":"2000","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.antiviral.2013.08.023","article-title":"Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance","volume":"100","author":"Burnham","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/14787210.2013.842466","article-title":"Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses","volume":"11","author":"Farrukee","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0031-1283281","article-title":"Influenza drug resistance","volume":"32","author":"Pizzorno","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1128\/AAC.00581-10","article-title":"Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays","volume":"54","author":"Nguyen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_85","unstructured":"Ampofo, W.K., Al Busaidy, S., Cox, N.J., Giovanni, M., Hay, A., Huang, S., Inglis, S., Katz, J., Mokhtari-Azad, T., and Peiris, M. (2011, January 7\u20139). Strengthening the influenza vaccine virus selection and development process. Presented at the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection, Geneva, Switzerland."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"D31","DOI":"10.1016\/j.vaccine.2008.07.078","article-title":"Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses","volume":"26","author":"Russell","year":"2008","journal-title":"Vaccine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity","volume":"152","author":"Liang","year":"1994","journal-title":"J. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ncomms1026","article-title":"Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus","volume":"1","author":"Medina","year":"2010","journal-title":"Nat. Commun."},{"key":"ref_89","first-page":"301","article-title":"Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin","volume":"386","author":"Krammer","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"504831","DOI":"10.1155\/2015\/504831","article-title":"Current and emerging cell culture manufacturing technologies for influenza vaccines","volume":"2015","author":"Milian","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/160.2.191","article-title":"Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs","volume":"160","author":"Katz","year":"1989","journal-title":"J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/viro.1993.1461","article-title":"Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses","volume":"196","author":"Meyer","year":"1993","journal-title":"Virology"},{"key":"ref_93","unstructured":"Ampofo, W.K., Azziz-Baumgartner, E., Bashir, U., Cox, N.J., Fasce, R., Giovanni, M., Grohmann, G., Huang, S., Katz, J., and Mironenko, A. (2014, January 1\u20133). Strengthening the influenza vaccine virus selection and development process. Presented at the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection, Geneva, Switzerland."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.320661","article-title":"Control of influenza and poliomyelitis with killed virus vaccines","volume":"195","author":"Salk","year":"1977","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.vaccine.2009.09.092","article-title":"Efficacy and safety of a live-attenuated influenza vaccine in adults 60 years of age and older","volume":"28","author":"Steele","year":"2009","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.addr.2014.10.002","article-title":"Live attenuated and inactivated viral vaccine formulation and nasal delivery: Potential and challenges","volume":"93","author":"Tlaxca","year":"2015","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0042-6822(76)90481-5","article-title":"Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine","volume":"69","author":"Laver","year":"1976","journal-title":"Virology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines","volume":"26","author":"Wong","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4049\/jimmunol.101.1.62","article-title":"Antibody response in humans to deoxycholate-treated influenza virus vaccine","volume":"101","author":"Duxbury","year":"1968","journal-title":"J. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.vaccine.2011.01.039","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of flublok(r) trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50\u201364 years of age","volume":"29","author":"Baxter","year":"2011","journal-title":"Vaccine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.79.2.173","article-title":"A study of conditions for the optimum production of PR8 influenza virus in chick embryos","volume":"79","author":"Miller","year":"1944","journal-title":"J. Exp. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1099-1654(199910\/12)9:4<237::AID-RMV252>3.0.CO;2-G","article-title":"The development of live-attenuated cold-adapted influenza virus vaccine for humans","volume":"9","author":"Maassab","year":"1999","journal-title":"Rev. Med. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/jvi.62.2.488-495.1988","article-title":"Four viral genes independently contribute to attenuation of live influenza A\/Ann Arbor\/6\/60 (H2N2) cold-adapted reassortant virus vaccines","volume":"62","author":"Snyder","year":"1988","journal-title":"J. Virol."},{"key":"ref_104","first-page":"554","article-title":"Identification of sequence changes in the cold-adapted, live-attenuated influenza vaccine strain, A\/Ann Arbor\/6\/60 (H2N2)","volume":"167","author":"Cox","year":"1988","journal-title":"Virology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/219645a0","article-title":"Plaque formation of influenza virus at 25 \u00b0C","volume":"219","author":"Maassab","year":"1968","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1086\/514173","article-title":"Improvement of inactivated influenza virus vaccines","volume":"176","author":"Couch","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.virol.2008.08.010","article-title":"Molecular studies of temperature-sensitive replication of the cold-adapted B\/Ann Arbor\/1\/66, the master donor virus for live-attenuated influenza flumist vaccines","volume":"380","author":"Chen","year":"2008","journal-title":"Virology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1128\/JVI.79.17.11014-11021.2005","article-title":"Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B\/Ann Arbor\/1\/66","volume":"79","author":"Hoffmann","year":"2005","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0042-6822(88)90284-X","article-title":"Sequence comparison of wild-type and cold-adapted B\/Ann Arbor\/1\/66 influenza virus genes","volume":"163","author":"DeBorde","year":"1988","journal-title":"Virology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0882-4010(87)90068-4","article-title":"Genetics of cold-adapted B\/Ann Arbor\/1\/66 influenza virus reassortants: The acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulence","volume":"3","author":"Donabedian","year":"1987","journal-title":"Microb. Pathog."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2008.07.027","article-title":"The cold adapted and temperature sensitive influenza A\/Ann Arbor\/6\/60 virus, the master donor virus for live-attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature","volume":"380","author":"Chan","year":"2008","journal-title":"Virology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/JVI.78.2.995-998.2004","article-title":"Imparting temperature sensitivity and attenuation in ferrets to A\/Puerto Rico\/8\/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A\/Ann Arbor\/6\/60","volume":"78","author":"Jin","year":"2004","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted A\/Ann Arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25 \u00b0C","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/JVI.02636-14","article-title":"Development of a mouse-adapted live-attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live-attenuated influenza virus vaccine","volume":"89","author":"Cox","year":"2015","journal-title":"J. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jaci.2014.02.009","article-title":"Influenza vaccination in asthmatic patients","volume":"133","author":"Greenhawt","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1098\/rstb.2001.0982","article-title":"Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children","volume":"356","author":"Belshe","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/iai.44.3.730-733.1984","article-title":"Recombinant cold-adapted attenuated influenza A vaccines for use in children: Molecular genetic analysis of the cold-adapted donor and recombinants","volume":"44","author":"Ghendon","year":"1984","journal-title":"Infect. Immun."},{"key":"ref_119","first-page":"493","article-title":"Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines","volume":"62","author":"Ghendon","year":"1984","journal-title":"Bull. World Health Organ."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live-attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Chen","year":"2011","journal-title":"Virology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1023\/A:1007327505862","article-title":"Cold-adapted live-attenuated influenza vaccines developed in russia: Can they contribute to meeting the needs for influenza control in other countries?","volume":"13","author":"Kendal","year":"1997","journal-title":"Eur. J. Epidemiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1016\/j.vaccine.2010.03.005","article-title":"Comparison of egg and high yielding MDCK cell-derived live-attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells","volume":"28","author":"Hussain","year":"2010","journal-title":"Vaccine"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/JVI.02106-09","article-title":"Generation of live-attenuated novel influenza virus A\/California\/7\/09 (H1N1) vaccines with high yield in embryonated chicken eggs","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/jb.48.3.369-378.1944","article-title":"Distribution of influenza virus type a in infected eggs and the survival of virus under certain conditions of storage","volume":"48","author":"Pearson","year":"1944","journal-title":"J. Bacteriol."},{"key":"ref_125","first-page":"10","article-title":"A flu vaccine shortage can be devastating for LTC residents","volume":"68","author":"Voyles","year":"2005","journal-title":"RN"},{"key":"ref_126","first-page":"563","article-title":"The politics of the flu vaccine shortage","volume":"102","author":"Stulc","year":"2004","journal-title":"J. Ky. Med. Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1586\/erv.09.128","article-title":"Continuous cell lines as a production system for influenza vaccines","volume":"8","author":"Genzel","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.vaccine.2010.03.029","article-title":"Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing","volume":"28","author":"Jacob","year":"2010","journal-title":"Vaccine"},{"key":"ref_129","first-page":"23","article-title":"Production of influenza virus in serum-free mammalian cell cultures","volume":"98","author":"Merten","year":"1999","journal-title":"Dev. Biol. Stand."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4899-1382-1_19","article-title":"Production of influenza virus in cell cultures for vaccine preparation","volume":"397","author":"Merten","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_131","first-page":"151","article-title":"Inactivated and adjuvanted influenza vaccines","volume":"386","author":"Rappuoli","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1016\/j.vaccine.2010.07.008","article-title":"Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I-II randomized trial","volume":"28","author":"Wu","year":"2010","journal-title":"Vaccine"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2014.11.062","article-title":"Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults","volume":"33","author":"Black","year":"2015","journal-title":"Vaccine"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/CVI.00475-15","article-title":"Persistence of antibody to influenza A\/H5N1 vaccine virus: Impact of AS03 adjuvant","volume":"23","author":"Chen","year":"2016","journal-title":"Clin. Vaccine. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3390\/v6072531","article-title":"RNA virus reverse genetics and vaccine design","volume":"6","author":"Stobart","year":"2014","journal-title":"Viruses"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-2438-7_13","article-title":"Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes","volume":"1282","author":"Almazan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1128\/JVI.00385-06","article-title":"Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis","volume":"80","author":"Almazan","year":"2006","journal-title":"J. Virol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.6272391","article-title":"Cloned poliovirus complementary DNA is infectious in mammalian cells","volume":"214","author":"Racaniello","year":"1981","journal-title":"Science"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Martinez-Sobrido, L., and Garcia-Sastre, A. (2010). Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp., 42.","DOI":"10.3791\/2057"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-2659.2012.00392.x","article-title":"Many ways to make an influenza virus\u2014Review of influenza virus reverse genetics methods","volume":"7","author":"Engelhardt","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1128\/JVI.01565-14","article-title":"Influenza a virus attenuation by codon deoptimization of the NS gene for vaccine development","volume":"88","author":"Nogales","year":"2014","journal-title":"J. Virol."},{"key":"ref_142","first-page":"206","article-title":"Replication-competent influenza A viruses expressing a red fluorescent protein","volume":"476C","author":"Nogales","year":"2014","journal-title":"Virology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/JVI.01433-09","article-title":"Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies","volume":"84","author":"Cadagan","year":"2010","journal-title":"J. Virol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virusres.2015.07.013","article-title":"Development and applications of single-cycle infectious influenza A virus (sciIAV)","volume":"216","author":"Nogales","year":"2015","journal-title":"Virus Res."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Breen, M., Nogales, A., Baker, S.F., and Martinez-Sobrido, L. (2016). Replication-competent influenza A viruses expressing reporter genes. Viruses, 8.","DOI":"10.3390\/v8070179"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virusres.2015.11.014","article-title":"Replication-competent fluorescent-expressing influenza B virus","volume":"213","author":"Nogales","year":"2015","journal-title":"Virus Res."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Breen, M., Nogales, A., Baker, S.F., Perez, D.R., and Martinez-Sobrido, L. (2016). Replication-competent influenza A and B viruses expressing a fluorescent dynamic timer protein for in vitro and in vivo studies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147723"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1093\/nar\/21.16.3607","article-title":"RNA polymerase I catalysed transcription of insert viral cDNA","volume":"21","author":"Zobel","year":"1993","journal-title":"Nucleic Acids Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/viro.1994.1365","article-title":"RNA polymerase I-mediated expression of influenza viral RNA molecules","volume":"202","author":"Neumann","year":"1994","journal-title":"Virology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/viro.1999.0140","article-title":"\u201cAmbisense\u201d approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template","volume":"267","author":"Hoffmann","year":"2000","journal-title":"Virology"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Cheng, B.Y., Ortiz-Riano, E., de la Torre, J.C., and Martinez-Sobrido, L. (2013). Generation of recombinant arenavirus for vaccine development in fda-approved vero cells. J. Vis. Exp., 78.","DOI":"10.3791\/50662"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1099\/vir.0.051102-0","article-title":"Arenavirus reverse genetics for vaccine development","volume":"94","author":"Cheng","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1743-422X-4-102","article-title":"Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells","volume":"4","author":"Wang","year":"2007","journal-title":"Virol. J."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"13811","DOI":"10.1128\/JVI.79.21.13811-13816.2005","article-title":"Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells","volume":"79","author":"Massin","year":"2005","journal-title":"J. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12985-015-0321-5","article-title":"Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid","volume":"12","author":"Zhang","year":"2015","journal-title":"Virol. J."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Lu, G., He, D., Wang, Z., Ou, S., Yuan, R., and Li, S. (2016). Cloning the horse RNA polymerase I promoter and its application to studying influenza virus polymerase activity. Viruses, 8.","DOI":"10.3390\/v8060119"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1128\/JVI.73.11.9679-9682.1999","article-title":"Rescue of influenza A virus from recombinant DNA","volume":"73","author":"Fodor","year":"1999","journal-title":"J. Virol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/JCM.03265-13","article-title":"Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics","volume":"52","author":"Zhou","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"11744","DOI":"10.1128\/JVI.76.22.11744-11747.2002","article-title":"A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA","volume":"76","author":"Jackson","year":"2002","journal-title":"J. Virol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1073\/pnas.172393399","article-title":"Rescue of influenza B virus from eight plasmids","volume":"99","author":"Hoffmann","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2011.09.035","article-title":"Taming influenza viruses","volume":"162","author":"Ozawa","year":"2011","journal-title":"Virus Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"9727","DOI":"10.1128\/JVI.01144-07","article-title":"Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions","volume":"81","author":"Marsh","year":"2007","journal-title":"J. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Isel, C., Munier, S., and Naffakh, N. (2016). Experimental approaches to study genome packaging of influenza A viruses. Viruses, 8.","DOI":"10.3390\/v8080218"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1098\/rstb.2001.0979","article-title":"Plasmid-only rescue of influenza A virus vaccine candidates","volume":"356","author":"Schickli","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","author":"Steel","year":"2009","journal-title":"J. Virol."},{"key":"ref_168","first-page":"177","article-title":"Attenuated influenza virus vaccines with modified NS1 proteins","volume":"333","author":"Richt","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1016\/j.vaccine.2007.09.019","article-title":"Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine","volume":"25","author":"Vincent","year":"2007","journal-title":"Vaccine"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1128\/JVI.79.13.8431-8439.2005","article-title":"Attenuation of equine influenza viruses through truncations of the NS1 protein","volume":"79","author":"Quinlivan","year":"2005","journal-title":"J. Virol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1099\/vir.0.80991-0","article-title":"Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins","volume":"86","author":"Falcon","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"13037","DOI":"10.1128\/JVI.78.23.13037-13045.2004","article-title":"Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes","volume":"78","author":"Ferko","year":"2004","journal-title":"J. Virol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1128\/JVI.00787-06","article-title":"Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine","volume":"80","author":"Richt","year":"2006","journal-title":"J. Virol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/JVI.79.12.7535-7543.2005","article-title":"Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs","volume":"79","author":"Solorzano","year":"2005","journal-title":"J. Virol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2008.05.001","article-title":"Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00705-015-2442-y","article-title":"Development of a dual-protective live-attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene","volume":"160","author":"Choi","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2016.10.008","article-title":"Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines","volume":"500","author":"Nogales","year":"2016","journal-title":"Virology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.1128\/JVI.00590-07","article-title":"Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus","volume":"81","author":"Baskin","year":"2007","journal-title":"J. Virol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1128\/JVI.01131-12","article-title":"NS1-truncated live-attenuated virus vaccine provides robust protection to aged mice from viral challenge","volume":"86","author":"Pica","year":"2012","journal-title":"J. Virol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"10580","DOI":"10.1128\/JVI.01213-08","article-title":"Influenza B virus NS1-truncated mutants: Live-attenuated vaccine approach","volume":"82","author":"Hai","year":"2008","journal-title":"J. Virol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1073\/pnas.070525997","article-title":"Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach","volume":"97","author":"Talon","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/JVI.03401-14","article-title":"Development of live-attenuated arenavirus vaccines based on codon deoptimization","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nbt.1636","article-title":"Live attenuated influenza virus vaccines by computer-aided rational design","volume":"28","author":"Mueller","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1073\/pnas.1307473110","article-title":"Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.vaccine.2012.07.059","article-title":"A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine","volume":"30","author":"Katsura","year":"2012","journal-title":"Vaccine"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.1128\/JVI.01820-12","article-title":"Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity","volume":"86","author":"Powell","year":"2012","journal-title":"J. Virol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/JVI.78.6.3083-3088.2004","article-title":"Characterization of a neuraminidase-deficient influenza A virus as a potential gene delivery vector and a live vaccine","volume":"78","author":"Shinya","year":"2004","journal-title":"J. Virol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1128\/JVI.00076-13","article-title":"A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges","volume":"87","author":"Uraki","year":"2013","journal-title":"J. Virol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1128\/JVI.06232-11","article-title":"A replication-incompetent PB2-knockout influenza A virus vaccine vector","volume":"86","author":"Victor","year":"2012","journal-title":"J. Virol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"12006","DOI":"10.1128\/JVI.01847-14","article-title":"Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus","volume":"88","author":"Guo","year":"2014","journal-title":"J. Virol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1128\/JVI.01348-13","article-title":"An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs","volume":"87","author":"Masic","year":"2013","journal-title":"J. Virol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00705-013-1932-z","article-title":"A recombinant influenza virus vaccine expressing the f protein of respiratory syncytial virus","volume":"159","author":"Fonseca","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.vaccine.2013.10.029","article-title":"A replication-incompetent influenza virus bearing the hn glycoprotein of human parainfluenza virus as a bivalent vaccine","volume":"31","author":"Kobayashi","year":"2013","journal-title":"Vaccine"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1128\/JVI.01205-14","article-title":"A bivalent vaccine based on a replication-incompetent influenza virus protects against streptococcus pneumoniae and influenza virus infection","volume":"88","author":"Katsura","year":"2014","journal-title":"J. Virol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1128\/JVI.02490-12","article-title":"Influenza viruses with rearranged genomes as live-attenuated vaccines","volume":"87","author":"Pena","year":"2013","journal-title":"J. Virol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Nogales, A., DeDiego, M.L., Topham, D.J., and Martinez-Sobrido, L. (2016). Rearrangement of influenza virus spliced segments for the development of live-attenuated vaccines. J. Virol.","DOI":"10.1128\/JVI.00410-16"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2013.11.001","article-title":"H5N1, a wealth of knowledge to improve pandemic preparedness","volume":"178","author":"Perez","year":"2013","journal-title":"Virus Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1128\/JVI.77.5.3148-3156.2003","article-title":"Role of quail in the interspecies transmission of H9 influenza A viruses: Molecular changes on HA that correspond to adaptation from ducks to chickens","volume":"77","author":"Perez","year":"2003","journal-title":"J. Virol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/v6051974","article-title":"Universal influenza vaccines, a dream to be realized soon","volume":"6","author":"Zhang","year":"2014","journal-title":"Viruses"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1016\/j.vaccine.2010.06.044","article-title":"In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine","volume":"28","author":"Song","year":"2010","journal-title":"Vaccine"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1128\/JVI.75.13.6154-6165.2001","article-title":"Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins","volume":"75","author":"Latham","year":"2001","journal-title":"J. Virol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1128\/JVI.00361-07","article-title":"Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1016\/j.vaccine.2011.06.068","article-title":"Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes","volume":"29","author":"Pushko","year":"2011","journal-title":"Vaccine"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/1\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:29:06Z","timestamp":1760210946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/1\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":206,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["ijms18010020"],"URL":"https:\/\/doi.org\/10.3390\/ijms18010020","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,22]]}}}